The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives
Authors:
- Massimo AndreoniMAMassimo Andreoni
- Matteo BassettiMatteo Bassetti
- Salvatore CorraoSalvatore Corrao
- Francesco Giuseppe De RosaFRFrancesco Giuseppe De Rosa
- Marco FalconeMFMarco Falcone
- Paolo GrossiPGPaolo Grossi
- Federico PeaFPFederico Pea
- Nicola PetrosilloNPNicola Petrosillo
- Carlo TasciniCTCarlo Tascini
- Mario VendittiMVMario Venditti
- Pierluigi VialePVPierluigi Viale
- 16 March 2021
- journal article
- other
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 19 (9) , 1125-1134
Abstract
The COVID-19 pandemic has dramatically challenged the national health systems worldwide in the last months. Dalbavancin is a novel antibiotic with a long plasmatic half-life and simplified weekly a...Keywords
Funding Information
- Angelini S.P.A
This publication has 51 references indexed in Scilit:
- Nosocomial infections: Epidemiology, prevention, control and surveillanceAsian Pacific Journal of Tropical Biomedicine, 2017
- In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infectionsDiagnostic Microbiology and Infectious Disease, 2016
- A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure InfectionClinical Infectious Diseases, 2015
- 2015 ESC Guidelines for the management of infective endocarditisEuropean Heart Journal, 2015
- Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular TissueAntimicrobial Agents and Chemotherapy, 2015
- Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin InfectionNew England Journal of Medicine, 2014
- Activities of Dalbavancin against a Worldwide Collection of 81,673 Gram-Positive Bacterial IsolatesAntimicrobial Agents and Chemotherapy, 2009
- OsteomyelitisThe Lancet, 2004
- Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolatesDiagnostic Microbiology and Infectious Disease, 2004
- Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditisThe American Journal of Medicine, 1985